Applying Genomics

The National Heart, Lung, and Blood Institute (NHLBI) recently launched a $37 million grant initiative to advance genomics research. This initiative consists of 11 Programs for Genomic Applications (PGAs) aimed at applying and expanding the data and technologies developed to map and sequence the human genome. The NHLBI considers this initiative one of its most ambitious to date, given that the goal is to identify the subsets of genes linked to heart, lung, blood, and sleep function, and to utili

Written byKate Devine
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The National Heart, Lung, and Blood Institute (NHLBI) recently launched a $37 million grant initiative to advance genomics research. This initiative consists of 11 Programs for Genomic Applications (PGAs) aimed at applying and expanding the data and technologies developed to map and sequence the human genome. The NHLBI considers this initiative one of its most ambitious to date, given that the goal is to identify the subsets of genes linked to heart, lung, blood, and sleep function, and to utilize the information to develop better methods for prevention, diagnosis, and therapy.

John Macauley, research scientist and director of the office of courses and conferences at the Jackson Laboratory in Bar Harbor, Maine, sums up the importance of the PGAs: "Once we have the sequence, where do we go from there? The answer is applied genomics. It is where we need to go and [this type of initiative] is what we ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies